These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 241789)

  • 1. The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethiazide.
    Corrigan OI; Timoney RF
    J Pharm Pharmacol; 1975 Oct; 27(10):759-64. PubMed ID: 241789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amorphous spray-dried hydroflumethiazide-polyvinylpyrrolidone systems: physiochemical properties.
    Corrigan OI; Holohan EM
    J Pharm Pharmacol; 1984 Apr; 36(4):217-21. PubMed ID: 6144766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction between macromolecular adjuvants and drugs. 24. Improvement of the solubility characteristics of benzodiazepine derivatives with polyvinylpyrrolidone].
    Keipert S; Voigt R
    Pharmazie; 1986 Jun; 41(6):400-4. PubMed ID: 2876444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of baicalin-poly -vinylpyrrolidone coprecipitate.
    Li B; Wen M; Li W; He M; Yang X; Li S
    Int J Pharm; 2011 Apr; 408(1-2):91-6. PubMed ID: 21291971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of polyvinylpyrrolidone on the solution and bioavailability of hydrochlorothiazide.
    Corrigan OI; Timoney RF; Whelan MJ
    J Pharm Pharmacol; 1976 Sep; 28(9):703-6. PubMed ID: 10394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions.
    Doherty C; York P
    J Pharm Pharmacol; 1989 Feb; 41(2):73-8. PubMed ID: 2568431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability study of amorphous valdecoxib.
    Ambike AA; Mahadik KR; Paradkar A
    Int J Pharm; 2004 Sep; 282(1-2):151-62. PubMed ID: 15336390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Physicochemical Investigation of 17β-Estradiol Crystalline Prepared by In Situ pH-Dependent Solubility Technique with Polyvinylpyrrolidone.
    Xiong H; Fu J; Sun H; Wang E; Ding Y; Ren G; Jing Q; Ren F
    AAPS PharmSciTech; 2017 Nov; 18(8):2889-2897. PubMed ID: 28424978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous is not always better-A dissolution study on solid state forms of carbamazepine.
    Jensen LG; Skautrup FB; Müllertz A; Abrahamsson B; Rades T; Priemel PA
    Int J Pharm; 2017 Apr; 522(1-2):74-79. PubMed ID: 28263832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
    Wu K; Li J; Wang W; Winstead DA
    J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of lutein-loaded particles for improving solubility and stability by Polyvinylpyrrolidone (PVP) as an emulsion-stabilizer.
    Zhao C; Cheng H; Jiang P; Yao Y; Han J
    Food Chem; 2014 Aug; 156():123-8. PubMed ID: 24629947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.
    Knopp MM; Nguyen JH; Mu H; Langguth P; Rades T; Holm R
    AAPS J; 2016 Mar; 18(2):416-23. PubMed ID: 26769250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
    Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
    Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.
    Forster A; Hempenstall J; Rades T
    J Pharm Pharmacol; 2001 Mar; 53(3):303-15. PubMed ID: 11291745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems.
    Corrigan OI; Stanley CT
    J Pharm Pharmacol; 1982 Oct; 34(10):621-6. PubMed ID: 6128383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.